About Us

       Fujian South Pharmaceutical Co., Ltd. 

(FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has developed into an major GMP manufacturer of Taxanes and other Oncology API and intermediates in China.
       FSP cultivates 800 hectare of Taxus Wallichiana locally and became the largest commercial utilizing factory in China to enable us a stable supply of 10-DAB III,which is key starting material for Paclitaxel and Docetaxel,as well as Cabazitaxel.
        FSP is the main manufacturer for Paclitaxel CP/IP/USP/EP (crude and API), Docetaxel IP/CP/USP/EP, 10-DAB III (Taxus Wallichiana and Taxus Baccata) and the side chains in the world.
       To ensure a sustainable and healthy development, FSP established Taxus nursery R&D center ....MORE >>

Meet us at

Booth No.:E1N12,CPhI China,Shanghai, June 24-26
Also meet us in coming CPhI Worldwide,Madrid 2015 and CPhI India 2015.
Please contact us by email for business meeting to sales@southpharma.com
Look forward to meeting you!

RD & Patent

Quality

Products List
Taxane Series
Paclitaxel Natural/Semi-Synthetic
Docetaxel Anhydrous/Trihydrate
10-Deacetyl Baccatin III, 10-DAB III
2’-Ac-Docetaxel
Cephalomannine
MORE
Taxane Side Chains
(4S,5R)-3-Benzoyl-2-(4-methoxyphenyl)-4-phenyl-5-oxazolidinecarboxylic acid
(4S,5R)-3-tert-Butoxycarbony-2-(4-anisyl)-4-phenyl-5-oxazolidinecarboxylic acid
Methyl (2R,3S)-N-Boc-3-Phenylisoserine
Methyl (2R,3S)-N-Benzoyl-3-Phenylisoserine
(2R,3S)-2-acetoxy-3-(bis(tert-butoxycarbonyl)amino)-3-phenylpropionic acid
MORE
Taxane impurity standards
10-Deacetyl Paclitaxel
Cephalomannine
Iso-cephalomannine
7-epi-10-Deacetyl-Paclitaxel
Paclitaxel C
MORE
Tinib series
Imatinib mesilate
Imatinib Base
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
4-(4-Methyl-piperazin-1-ylmethyl)-benzoic acid methyl ester
MORE
Tabine series
Gemcitabine HCl
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate (T6)
2-Deoxy-2,2-Difluoro-D-Ribofuranose-3,5-Dibenzoate(T7)
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate (T8)
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (T9)
MORE
Camptothecin Series
Irinotecan Hydrochloride Trihydrate
7-Ethyl-10-hydroxycamptothecin (SN-38)
Topotecan HCl
10-Hydroxycamptothecin
1-Chlorocarbonyl-4-piperidinoperidine
MORE
Other Oncology Series
Bortezomib
(1S,2S,3R,5S)-2,3-Pinanediol
Pemetrexed disodium
Letrozole
Anastrozole
MORE
Ophthalmic Series
Dorzolamide HCL
(±)5,6-Dihydro-4-oxo-6-methyl-4H-Thieno(2,3B)thiopyran-2-sulfonamide
Brimonidine Tartrate
5-Aminolevulinic Acid HCL(5-ALA)
5-aminolevulinic acid
MORE
Other series
Aloe Emodin
Diacerein
Deferasirox
Tamsulosin HCl
Sitagliptin Phosphate
MORE
Under R&D
Aliskiren
Ticagrelor
Epothilone D
Epothilone E
Latanoprost
MORE
Note: All the above products are not offered for sale in countries and regions where the sale of such products constitutes a patent infringement, and liability for patent infringement is exclusively understood at buyer’s risk. Product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany,etc.